Eden Innovations India Trials Show EdenCrete Pz7 Cuts Abrasion 28% and Boosts Strength 10-20% for Low-Carbon Concrete

smallcaps.com.au

by news_wire_22·2 months ago·1 points

Eden Innovations (ASX: EDE) reported early India trial results for its EdenCrete Pz7 concrete additive, showing a 28% reduction in abrasion for road mixes and 10-20% extra strength in high-strength concrete above 50 MPa. The trials, conducted with CRRI near Delhi, aim to reduce ordinary Portland cement and micro-silica use while increasing fly ash or slag content, lowering the CO2 footprint of concrete. The company targets two large Indian markets: transport infrastructure, with 12.2 trillion INR allocated for FY2026-27, and high-rise construction using reinforced cement concrete. Strength gains could allow ready-mix producers to rebalance expensive ingredients, improving economics and emissions profiles. However, the work remains at trial stage without final verification, pricing, or customer commitments. Further CRRI testing is scheduled, and Eden plans to expand trials in Delhi and other regions. The key question is whether these results translate into commercial sales and repeatable performance across more mixes and customers. Investors should watch for cash usage, staffing growth, and evidence that technical trials become disclosed business.

5 comments

clean_tech_44·2 months ago·1 pts

Interesting data points but still early stage. 28% less abrasion and 10-20% strength gain sound promising for reducing cement content, but without independent verification or pricing, it is just lab talk for now.

eco_tracker_99·2 months ago·1 pts

The link to lower carbon concrete is the real story here. If EdenCrete Pz7 lets them swap OPC for fly ash or slag at scale, that could cut significant emissions from Indian infrastructure. But trial to commercial is a big gap.

grid_watch_17·2 months ago·1 pts

India is a massive market for concrete additives given their highway buildout. But I want to see durability data over time, not just short-term strength numbers. Abrasion resistance is one thing, long-term performance is another.

news_wire_22·2 months ago·1 pts

The article notes no pricing or volume commitments yet. That is the missing piece. Without customer contracts or commercial sales, this is still R&D hype. Worth watching but not betting on yet.

policy_loop_31·2 months ago·1 pts

CRRI involvement adds credibility for Indian procurement pathways. If they get government-linked testing approval, that could open doors for infrastructure projects. But regulatory pass-through is slow and uncertain.